Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 571190-30-2
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
571190-30-2 |
Appearance:: |
White To Beige Powder |
Molecular Formula:: |
C24H29N7O2 |
Molecular Weight:: |
447.53300 |
EINECS NO:: |
810-186-2 |
MDL NO:: |
MFCD11840850 |
CAS NO:: |
571190-30-2 |
Appearance:: |
White To Beige Powder |
Molecular Formula:: |
C24H29N7O2 |
Molecular Weight:: |
447.53300 |
EINECS NO:: |
810-186-2 |
MDL NO:: |
MFCD11840850 |
Product Description:
Product Name: palbociclib CAS NO: 571190-30-2
Synonyms:
Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];
N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide
Chemical & Physical Properties:
Appearance: White to beige powder
Assay: ≥99.0%
Density: 1.313g/cm3
Boiling Point: 711.5℃ at 760 mmHg
Melting Point: 200℃
Flash Point: 384.1℃
Refractive Index: 1.647
Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was discovered at Warner- Lambert and developed by Pfizer after their merger. Pfizer is also studying the effectiveness of palbociclib in a variety of other cancers at various stages in the clinic.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
